# Biotech Investment Analyst - Drug Asset & Company Assessment

**Company:** [Weekday AI](null/companies/pxG9rDgnvZm2c86JUchT1j.md)
**Location:** Remote
**Workplace:** remote
**Employment type:** Contract
**Department:** AI Training

[Apply for this job](null/view/24b410c3-0b22-4e6d-8ae0-2252cc5a103a)

## Description

**This role is for one of our clients**

**Compensation: $120 - $200 per hour**

We are partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

## Requirements

**Responsibilities**

-   Create and critique rubrics that analyze commercial drugs and drug-development programs
-   Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
-   Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
-   Apply your assessment across the pilot's set of companies (~5–10)

**Requirements**

-   US-based biotech / healthcare investment analyst with a specialist-fund background
-   Familiarity with biotech/pharma development programs
-   Able to assess a drug asset and the company behind it end-to-end
-   5+ years evaluating biotech/pharma companies or assets

**Engagement Details**

-   Duration: Approximately 10–20 hours over a 1–2 week pilot
-   Remote — US-based

**Why Participate**

-   Help improve expert AI evaluation of drugs and drug-development programs
-   Recurring engagement for strong contributors

We consider all qualified applicants without regard to legally protected characteristics and provide reasonable accommodations upon request.